[Platelet aggregation inhibitor and brain infarct: quo vadis?].
Bogousslavsky
J
J
Neurologische Abteilung, CHUV, Lausanne.
D001241:Aspirin / Q000627:therapeutic use; D002544:Cerebral Infarction / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin
Thrombozytenaggregationshemmer und Hirninfarkt: quo vadis?